Why the study?
The study was conducted to investigate gender differences in epicardial adipose tissue and plaque composition by coronary CT angiography and their association with cardiovascular outcome.
Do gender differences in epicardial adipose tissue and plaque composition by CCTA predict cardiovascular outcomes in patients with suspected CAD?
Do gender differences in epicardial adipose tissue and plaque composition by CCTA predict cardiovascular outcomes in patients with suspected CAD?
Low-attenuation plaque on CCTA is an independent predictor of MACE in both men and women with suspected CAD, despite women having less overall plaque burden and EAT volume.
May refine CCTA risk stratification across sexes; extends sex-specific plaque data but remains hypothesis-generating.
Background: To investigate gender differences in epicardial adipose tissue (EAT) and plaque composition by coronary CT angiography (CCTA) and the association with cardiovascular outcome. Methods: Data of 352 patients (64.2 ± 10.3 years, 38% female) with suspected coronary artery disease (CAD) who underwent CCTA were retrospectively analyzed. EAT volume and plaque composition from CCTA were compared between men and women. Major adverse cardiovascular events (MACE) were recorded from follow-up. Results: Men were more likely to have obstructive CAD, higher Agatston scores, and a larger total and non-calcified plaque burden. In addition, men displayed more adverse plaque characteristics and EAT volume compared to women (all p < 0.05). After a median follow-up of 5.1 years, MACE occurred in 8 women (6%) and 22 men (10%). In multivariable analysis, Agatston calcium score (HR 1.0008, p = 0.014), EAT volume (HR 1.067, p = 0.049), and low-attenuation plaque (HR 3.82, p = 0.036) were independent predictors for MACE in men, whereas only low-attenuation plaque (HR 2.42, p = 0.041) showed predictive value for events in women. Conclusion: Women demonstrated less overall plaque burden, fewer adverse plaque characteristics, and a smaller EAT volume compared to men. However, low-attenuation plaque is a predictor for MACE in both genders. Thus, a differentiated plaque analysis is warranted to understand gender differences of atherosclerosis to guide medical therapy and prevention strategies.
No takes yet. Share an insight, caveat, or question.
Ebersberger et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: